In conclusion, our study reveals the mechanism by which the TRAF6/IRF3 axis decreases GC’s cells sensitivity to 5-FU by promoting nuclear translocation of NF-κB-p65, offering valuable insights into overcoming chemoresistance in GC. Here, TRAF6 is linked to gastric cancer.